A study that shows cell type-dependent variability of spike protein production by COVID-19 vaccines leads an antivaxxer to say how little we know about the vaccines.

A study that shows cell type-dependent variability of spike protein production by COVID-19 vaccines leads an antivaxxer to say how little we know about the vaccines.
On Monday the FDA granted full approval to Comirnaty, the COVID-19 vaccine developed by Pfizer and BioNTech. By Tuesday, antivaxxers had a propaganda line that the vaccine is still “experimental.”